Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Weigao Eyes Automation To Ease Acute Labor Shortage: China Earnings Roundup (Part 4)

This article was originally published in PharmAsia News

Executive Summary

Labor shortages and higher salaries have led Shandong Weigao Group Medical Polymer Co. Ltd. to invest in automation as the firm plans to open three more dialysis centers.

You may also be interested in...



Are China's Rising Labor Costs Good For Big Pharma?

HONG KONG - Rising labor costs are putting stress on manufacturing operations in China, but may prove to be a boon in the long term for companies focused on the world's fastest-growing domestic market

China's Leading Medical Consumables Device Maker Weigao Plans New Share Offering In Hong Kong; JV With MNCs To Explore New Landscape

SHANGHAI - Weihai-based Shandong Weigao Group Medical Polymer Company Limited, the leading Chinese medical consumables manufacturer and Medtronic Inc., which holds 15% of its total stake, is planning a secondary offering of 85.6 million H shares in Hong Kong to raise roughly HK$1.736 billion ($223 million) to expand its production capability and fund potential merger and acquisitions

Behind The First Inhaled COVID Vaccine: Chinese-Language CEO Podcast With CanSino’s Xuefeng Yu

After securing the first approval globally for an inhaled COVID-19 vaccine, Chinese biotech CanSino CEO Xuefeng Yu sat down with Scrip in this Chinese-language interview to share his views on vaccine development and market opportunities in China and elsewhere.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

SC080668

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel